Vol.41 No.3 (293 in total) Mar. 2025
Theme Issue: Clinical Application and Research Progress of Albumin in Liver Disease
Chief Editor: JIA Jidong
Beijing Friendship Hospital, Capital Medical University
Display Method:
2025, 41(3): 401-403.
DOI: 10.12449/JCH250301
Abstract
HTML
PDF (508KB)
Abstract:
Albumin is the most abundant protein in human plasma， and in addition to the function of maintaining plasma colloid osmotic pressure， it also has the functions of material transport， detoxification， maintaining vascular integrity， antioxidation， anti-inflammat...
Albumin is the most abundant protein in human plasma， and in addition to the function of maintaining plasma colloid osmotic pressure， it also has the functions of material transport， detoxification， maintaining vascular integrity， antioxidation， anti-inflammat...
2025, 41(3): 404-408.
DOI: 10.12449/JCH250302
Abstract:
As an important protein synthesized by the liver， albumin is one of the most important markers for liver function， and its structure and function change with the progression of liver injury. Latest studies have shown that albumin in the disease state is not on...
As an important protein synthesized by the liver， albumin is one of the most important markers for liver function， and its structure and function change with the progression of liver injury. Latest studies have shown that albumin in the disease state is not on...
2025, 41(3): 409-414.
DOI: 10.12449/JCH250303
Abstract:
Albumin is synthesized in the liver， and in case of severe liver injury， albumin synthesis is reduced with structural alterations （such as an increase in methylation and glycosylation）， leading to a significant reduction in effective albumin in circulation. Al...
Albumin is synthesized in the liver， and in case of severe liver injury， albumin synthesis is reduced with structural alterations （such as an increase in methylation and glycosylation）， leading to a significant reduction in effective albumin in circulation. Al...
2025, 41(3): 415-419.
DOI: 10.12449/JCH250304
Abstract:
Human serum albumin （HSA） is the most abundant protein in plasma and has many biological functions and clinical applications. An adequate and stable supply of functional HSA molecules that are easy to store and have a long half-life is still an unmet clinical ...
Human serum albumin （HSA） is the most abundant protein in plasma and has many biological functions and clinical applications. An adequate and stable supply of functional HSA molecules that are easy to store and have a long half-life is still an unmet clinical ...
2025, 41(3): 420-423.
DOI: 10.12449/JCH250305
Abstract:
Albumin is widely used in clinical practice， and the rationality of trial design directly affects the reliability of research findings and clinical application value. This article reviews the key statistical considerations in the design of albumin clinical tri...
Albumin is widely used in clinical practice， and the rationality of trial design directly affects the reliability of research findings and clinical application value. This article reviews the key statistical considerations in the design of albumin clinical tri...
2025, 41(3): 432-441.
DOI: 10.12449/JCH250307
Abstract:
Intrahepatic cholangiocarcinoma （ICC） is a highly heterogeneous tumor， and molecular profiling serves as the foundation for personalized treatment of ICC. Accurate detection methods are clinically significant for comprehensively screening patients suitable for...
Intrahepatic cholangiocarcinoma （ICC） is a highly heterogeneous tumor， and molecular profiling serves as the foundation for personalized treatment of ICC. Accurate detection methods are clinically significant for comprehensively screening patients suitable for...
2025, 41(3): 442-445.
DOI: 10.12449/JCH250308
Abstract:
In November 2024， the Expert Group on Alcohol-related Liver Disease released a position statement on metabolic dysfunction and alcohol-related liver disease （MetALD）. MetALD is a new subtype of steatotic liver disease and refers to MASLD patients with a relati...
In November 2024， the Expert Group on Alcohol-related Liver Disease released a position statement on metabolic dysfunction and alcohol-related liver disease （MetALD）. MetALD is a new subtype of steatotic liver disease and refers to MASLD patients with a relati...
2025, 41(3): 446-452.
DOI: 10.12449/JCH250309
Abstract:
Objective To evaluate the methodological quality and reporting quality of published guidelines/consensuses on traditional Chinese medicine （TCM）/integrated traditional Chinese and Western medicine diagnosis and treatment of nonalcoholic fatty liver disease （NA...
2025, 41(3): 453-460.
DOI: 10.12449/JCH250310
Abstract:
Objective To investigate the expression levels of miR-128-3p， SIRT1， and AMPK in the peripheral blood of patients with type 2 diabetes mellitus （T2DM） comorbid with nonalcoholic fatty liver disease （NAFLD）， as well as the role of miR-128-3p in predicting NAFLD...
2025, 41(3): 461-468.
DOI: 10.12449/JCH250311
Abstract:
Objective To investigate the heterogeneity and transcriptomic characteristics of T-cell subsets in the liver of mice with nonalcoholic steatohepatitis （NASH） at the single-cell level using single-cell RNA sequencing （scRNA-seq）， and to provide a reference for ...
2025, 41(3): 469-477.
DOI: 10.12449/JCH250312
Abstract:
Objective To investigate the effect of Yiqi Yangyin Jiedu Huayu prescription on minimal hepatic encephalopathy in liver cirrhosis based on intestinal metabolomics. Methods A total of 11 patients with liver cirrhosis who were hospitalized in Beijing Ditan Hospi...
2025, 41(3): 478-484.
DOI: 10.12449/JCH250313
Abstract:
Objective To investigate the effect of the nitroglycerin-controlled low central venous pressure （CLCVP） technique on brain metabolic markers and cerebral blood oxygen saturation in patients undergoing laparoscopic hepatectomy for liver cancer， and to reduce th...
2025, 41(3): 485-492.
DOI: 10.12449/JCH250314
Abstract:
Objective To investigate the role and mechanism of Go-Ichi-Ni-San complex subunit 1 （GINS1） in the progression of hepatocellular carcinoma （HCC） and the development of chemotherapy resistance. Methods The tumor database GEPIA2 was used to analyze the different...
2025, 41(3): 493-498.
DOI: 10.12449/JCH250315
Abstract:
Objective To investigate the effect of gallic acid （GA） on the proliferation， migration， invasion， and apoptosis of human hepatocellular carcinoma HepG2 cells and its mechanism. Methods HepG2 cells were treated with different concentrations of GA （0， 5， 10， 20...
2025, 41(3): 499-505.
DOI: 10.12449/JCH250316
Abstract:
Objective To investigate the role and mechanism of action of paeoniflorin （PF） in protecting HepG2 cells induced by palmitic acid （PA）. Methods HepG2 cells were stimulated with PA at a concentration of 250 μmol/L to establish a NAFLD model. Compound C at a con...
2025, 41(3): 506-512.
DOI: 10.12449/JCH250317
Abstract:
Objective To analyze the factors influencing meropenem-related liver injury （MRLI） and to explore their clinical predictive value. Methods A retrospective case-control study was conducted， and the Chinese Hospital Pharmacovigilance System （CHPS） was used to es...
2025, 41(3): 513-517.
DOI: 10.12449/JCH250318
Abstract:
Objective To investigate the feasibility and safety of endoscopic retrograde cholangiopancreatography （ERCP） combined with oral cholangiopancreatography in the treatment of major duodenal papilla gallbladder polyps. Methods A retrospective analysis was perform...
2025, 41(3): 518-527.
DOI: 10.12449/JCH250319
Abstract:
Objective To develop a predictive model and application for spontaneous passage of common bile duct stones using automated machine learning algorithms given the complexity of treatment decision-making for patients with common bile duct stones， and to reduce un...
2025, 41(3): 528-535.
DOI: 10.12449/JCH250320
Abstract:
Objective To investigate the influencing factors for traditional Chinese medicine （TCM） syndromes in pancreatic cancer by analyzing 608 cases， and to provide a theoretical reference for TCM syndrome differentiation and standardized treatment of pancreatic canc...
2025, 41(3): 536-541.
DOI: 10.12449/JCH250321
Abstract:
Hepatic angiomyolipoma （HAML） is a rare benign mesenchymal tumor frequently observed in middle-aged women. Due to the absence of prominent symptoms in the early stage and the lack of specific imaging findings， the diagnosis of this disease can be challenging， ...
Hepatic angiomyolipoma （HAML） is a rare benign mesenchymal tumor frequently observed in middle-aged women. Due to the absence of prominent symptoms in the early stage and the lack of specific imaging findings， the diagnosis of this disease can be challenging， ...
2025, 41(3): 542-546.
DOI: 10.12449/JCH250322
Abstract:
Some patients with drug-induced liver injury （DILI） may present with similar features to patients with autoimmune hepatitis （AIH）， and such cases are defined as drug-induced autoimmune-like hepatitis （DI-ALH）. In 2022， the European Association for the Study of...
Some patients with drug-induced liver injury （DILI） may present with similar features to patients with autoimmune hepatitis （AIH）， and such cases are defined as drug-induced autoimmune-like hepatitis （DI-ALH）. In 2022， the European Association for the Study of...
2025, 41(3): 547-551.
DOI: 10.12449/JCH250323
Abstract:
Autoimmune hepatitis （AIH） is a chronic inflammatory liver disease. The pathogenesis of AIH remains unclear， but it is mainly autoimmune injury caused by the breakdown of autoimmune tolerance due to the abnormal activation of the immune system， while the speci...
Autoimmune hepatitis （AIH） is a chronic inflammatory liver disease. The pathogenesis of AIH remains unclear， but it is mainly autoimmune injury caused by the breakdown of autoimmune tolerance due to the abnormal activation of the immune system， while the speci...
2025, 41(3): 552-555.
DOI: 10.12449/JCH250324
Abstract:
Hepatitis B cirrhosis is the most significant component of liver cirrhosis in China， and there is a significant increase in the mortality rate of patients after progression from hepatitis to liver cirrhosis. A large number of studies have shown that gut microb...
Hepatitis B cirrhosis is the most significant component of liver cirrhosis in China， and there is a significant increase in the mortality rate of patients after progression from hepatitis to liver cirrhosis. A large number of studies have shown that gut microb...
2025, 41(3): 556-560.
DOI: 10.12449/JCH250325
Abstract:
The Model for End-Stage Liver Disease （MELD） score is currently used to prioritize liver allocation for cirrhotic patients awaiting liver transplantation in the world. With the application of MELD score in transplantation for patients with severe conditions， s...
The Model for End-Stage Liver Disease （MELD） score is currently used to prioritize liver allocation for cirrhotic patients awaiting liver transplantation in the world. With the application of MELD score in transplantation for patients with severe conditions， s...
2025, 41(3): 561-567.
DOI: 10.12449/JCH250326
Abstract:
Mesenchymal stem cells （MSCs） have emerged as a promising cellular therapy for end-stage liver disease （ESLD） due to their robust self-regenerative， paracrine， and immunomodulatory characteristics， providing new directions for the treatment of advanced liver d...
Mesenchymal stem cells （MSCs） have emerged as a promising cellular therapy for end-stage liver disease （ESLD） due to their robust self-regenerative， paracrine， and immunomodulatory characteristics， providing new directions for the treatment of advanced liver d...
2025, 41(3): 568-573.
DOI: 10.12449/JCH250327
Abstract:
Acute-on-chronic liver failure （ACLF） is a dangerous disease with severe conditions， rapid progression， and high short-term mortality. Intestinal flora and metabolites are closely associated with the development， progression， and pathogenesis of ACLF. During t...
Acute-on-chronic liver failure （ACLF） is a dangerous disease with severe conditions， rapid progression， and high short-term mortality. Intestinal flora and metabolites are closely associated with the development， progression， and pathogenesis of ACLF. During t...
2025, 41(3): 574-579.
DOI: 10.12449/JCH250328
Abstract:
Liver failure is a common severe syndrome of liver diseases with high mortality. The function and structural integrity of the intestinal barrier as an entity are closely associated with the development and progression of liver failure. The cGAS-STING signaling...
Liver failure is a common severe syndrome of liver diseases with high mortality. The function and structural integrity of the intestinal barrier as an entity are closely associated with the development and progression of liver failure. The cGAS-STING signaling...
2025, 41(3): 580-587.
DOI: 10.12449/JCH250329
Abstract:
After 50 years of clinical development， endoscopic retrograde cholangiopancreatography （ERCP） has become the preferred method for the clinical diagnosis and treatment of cholangio-pancreatic duct diseases； however， the major postoperative complications of ERCP...
After 50 years of clinical development， endoscopic retrograde cholangiopancreatography （ERCP） has become the preferred method for the clinical diagnosis and treatment of cholangio-pancreatic duct diseases； however， the major postoperative complications of ERCP...
2025, 41(3): 588-593.
DOI: 10.12449/JCH250330
Abstract:
Intrahepatic cholangiocarcinoma is a malignant tumor with an extremely poor prognosis， and its pathogenesis is complex and remains unclear. In recent years， more and more studies have focused on the role of bile-gut axis in the development and progression of i...
Intrahepatic cholangiocarcinoma is a malignant tumor with an extremely poor prognosis， and its pathogenesis is complex and remains unclear. In recent years， more and more studies have focused on the role of bile-gut axis in the development and progression of i...
2025, 41(3): 594-600.
DOI: 10.12449/JCH250331
Abstract:
Intrahepatic cholangiocarcinoma （ICC） is a highly malignant liver tumor， and due to the absence of symptoms in its early stage and the lack of effective treatment measures， patients tend to have an extremely low 5-year survival rate. The tumor stroma-immune mi...
Intrahepatic cholangiocarcinoma （ICC） is a highly malignant liver tumor， and due to the absence of symptoms in its early stage and the lack of effective treatment measures， patients tend to have an extremely low 5-year survival rate. The tumor stroma-immune mi...
2025, 41(3): 484-484.
DOI: 10.12449/JCH2503.gwqkjpwzjj1
Abstract:
2025, 41(3): 546-546.
DOI: 10.12449/JCH2503.gwqkjpwzjj3
Abstract:
2025, 41(3): 567-567.
DOI: 10.12449/JCH2503.gwqkjpwzjj4
Abstract:
2025, 41(3): 587-587.
DOI: 10.12449/JCH2503.gwqkjpwzjj5
Abstract:
2025, 41(3): 306-306.
DOI: 10.12449/JCH2503.zhixie
Abstract:
2015, 31(12): 1941-1960.
doi: 10.3969/j.issn.1001-5256.2015.12.002
Abstract:
2019, 35(12): 2706-2711.
doi: 10.3969/j.issn.1001-5256.2019.12.013
Abstract:
2011, 27(1): 113-128.
Abstract:
2018, 34(10): 2109-2120.
doi: 10.3969/j.issn.1001-5256.2018.10.011
Abstract:
2015, 31(12): 1980-1988.
doi: 10.3969/j.issn.1001-5256.2015.12.004
Abstract:
2017, 33(8): 1419-1431.
doi: 10.3969/j.issn.1001-5256.2017.08.003
Abstract:
2016, 32(1): 9-22.
doi: 10.3969/j.issn.1001-5256.2016.01.002
Abstract:
2011, 27(1): 110-112.
Abstract:
2019, 35(12): 2648-2669.
doi: 10.3969/j.issn.1001-5256.2019.12.007
Abstract:
Top View Top DownloadMore>
- 1Current situation in the research of Gilbert’s syndrome
- 2Review of acute pancreatitis scoring systems
- 3Clinical value of 13C-methacetin breath test for assessing liver function in patients with cirrhosis
- 4Studies on relevant gactors of Child-Pugh grading in hepatic cirrhosis
- 5Meta-analysis of 111 patients with nonalcoholic steatohepatitis-associated hepatocellular carcinoma
- 6Research state and prospect of hyponatremia in cirrhosis
- 7Relationship between Epstein-Barr virus infection and hepatic lesions in children
- 8Congenital bile acid synthesis defect and cholestatic liver disease
- 9Interventional treatment for Budd-Chiari syndrome:reports of 883 cases
- 10
- 1The guideline of prevention and treatment for chronic hepatitis B: a 2015 update
- 2Chinese guidelines for the management of acute pancreatitis ( Shenyang , 2019 )
- 3The guideline of prevention and treatment for chronic hepatitis B(2010 version)
- 4Comprehensive guidelines for the diagnosis and treatment of pancreatic cancer (2018 version)
- 5Consensus on the diagnosis and management of primary biliary cirrhosis (cholangitis)(2015)
- 6Diagnosis, management, and treatment of hepatocellular carcinoma (V2017)
- 7Consensus on the diagnosis and management of autoimmune hepatitis(2015)
- 8Current situation in the research of Gilbert’s syndrome
- 9Guidelines for the prevention and treatment of chronic hepatitis B (version 2019)
- 10
International Database
-
-
荷兰《医学文摘（网络版）》（Embase）（2023—） -
荷兰《文摘与引文索引》（Scopus）（2021—） -
美国《化学文摘（网络版）》（CA）来源期刊（2011—） -
瑞士《健康网络首创研究获取》（HINARI）来源期刊（1985—） -
美国《艾博思科数据库》（Eh，EBSCOhost）来源期刊（2013—） -
英国《欧洲学术出版中心数据库》（EuroPub）来源期刊（2024—） -
英国《国际农业与生物科学研究中心》（CABI）来源期刊（2011—） -
《日本科学技术振兴机构数据库（中国）》（JSTChina）来源期刊（2018—） -
世界卫生组织《西太平洋地区医学索引（WPRIM）》来源期刊（2016—） -
美国《剑桥科学文摘》（CSA）来源期刊（2011—） -
俄罗斯《文摘杂志》（AJ，VINITI）来源期刊（2013—） -
美国《乌利希期刊指南（网络版）》（Ulrichsweb）注册期刊（2018—） -
波兰《哥白尼索引》（ICI）来源期刊（2011—）
